Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.59B | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | $10.97B | $10.64B |
| Cost of revenue | $5.33B | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | $4.94B | $4.70B |
| Gross profit | $7.27B | $6.27B | $6.54B | $6.29B | $6.29B | $5.89B | $6.03B | $5.94B |
| Gross margin | 57.7% | 56.2% | 57.0% | 55.4% | 56.4% | 56.9% | 55.0% | 55.8% |
| Research and development | $892.00M | $767.00M | $735.00M | $766.00M | $725.00M | $716.00M | $749.00M | $713.00M |
| Selling, general and administrative | $4.03B | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | $2.91B | $2.90B |
| Operating expenses | $5.58B | $4.93B | $4.29B | $4.24B | $4.24B | $4.20B | $4.12B | $4.08B |
| Operating income | $1.69B | $1.35B | $2.25B | $2.06B | $2.05B | $1.69B | $1.91B | $1.86B |
| Operating margin | 13.4% | 12.0% | 19.6% | 18.1% | 18.4% | 16.3% | 17.4% | 17.5% |
| EBITDA | $2.75B | $2.15B | $3.04B | $2.85B | $2.83B | $2.45B | $2.72B | $2.66B |
| Interest income | $52.00M | $106.00M | $78.00M | $77.00M | $71.00M | $82.00M | $91.00M | $91.00M |
| Interest expense | −$351.00M | −$174.00M | −$120.00M | −$121.00M | −$121.00M | −$131.00M | −$136.00M | −$142.00M |
| Income before taxes | $1.52B | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | $2.03B | $1.94B |
| Income taxes | $596.00M | $372.00M | $582.00M | $536.00M | $371.00M | $453.00M | −$7.20B | $294.00M |
| Net income | $928.00M | $1.08B | $1.78B | $1.64B | $1.78B | $1.33B | $9.23B | $1.65B |
| Net margin | 7.4% | 9.6% | 15.5% | 14.5% | 16.0% | 12.8% | 84.1% | 15.5% |
| EPS, basic | $0.53 | $0.62 | $1.00 | $0.94 | $1.02 | $0.76 | $5.22 | $0.94 |
| EPS, diluted | $0.53 | $0.61 | $1.03 | $0.94 | $1.01 | $0.76 | $5.39 | $0.94 |
| Diluted shares | 1.74B | 1.75B | 1.72B | 1.75B | 1.75B | 1.75B | 1.71B | 1.75B |
Figures describe Abbott shares, not any token. As of Jul 28, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.